微信

Precision Medicine

Venus

Hereditary Disease and Disease Susceptibility Testing

Personalized Tumor Biomarker Testing

Venus

Hereditary Disease and Disease Susceptibility Testing

Personalized Tumor Biomarker Testing

By using clinical data and applying advanced technology such as Modern Genetic Technology, Molecular Imaging, Bioinformatics, Precision Medicine offers personalized health promotion, health education and health protection solutions that that aims to reduce the risk factors from developing a disease. Traditional clinical-experience decision-making that most hospitals practice fails to make rational use of medical resources and lacks consistency in medical effect. Of the total medical expenditure in the United States, 30% of medical expenditures, which is up to 750 billion dollars, is wasted due to unnecessary or ineffective treatment. In China, the number for ineffective treatment is even higher. Rapid development in medicine has already transformed the landscape in medical research and clinical application. Precision Medicine and Translational Research uses the most cutting-edge technology and the most innovative medical models in Genomics, Proteomics, Metabolite. Moreover, advances in Genomic Bioresearch and screening technology has enabled clinic diagnostics enter a new Era of Precision Medicine. We now have a better understanding of illnesses and can make medical predictions through research in Genomics, Molecular Imaging, and Big Data analysis. The development of Precision Medicine has also increased the effectiveness of treatment, decreased the side-effects of drugs and brought down the medical expenditure in clinical diagnostics and treatment. Since Biotecan has been founded in 2008, we have focused on Precision Medicine-related medical research and specialized in services, from the collection and analysis of medical big data to the application and development of clinical diagnosis and treatment. The joint efforts of Biotecan and the Second Medical Military University have established Shanghai Zhangjiang National Independent Demonstration Zone Medical Big Data Public Service Platform, a Medical Big Data Platform concentrated on the research and treatment of tumor.

In addition, Biotecan uses strict quality management control system and is one of the earliest profit-earning medical molecular testing facilities in Shanghai. Our company strictly follows China’s GLP (Good Laboratory Practice of Drugs) standards and has the International CAP Certification, and China’s Genetic Clinical Laboratory Certification (PCR). Biotecan offers products and services ranging from illnesses related to tumor, maternal and child health, cardiovascular disease, infectious disease, and cater to your needs: Screening, Precise Diagnostics, Treatment, Management, Prognostics.

  • Contact Us
  • Shanghai Biotecan Pharmaceuticals Co. , Ltd.
  • Telephone:+86-21-50277725
  • Address

    First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China

Copyright © 2015-2018 Shanghai Biotecan Pharmaceuticals Co.,Ltd All Rights Reserved 沪ICP备09055310号-1 沪公网安备 31011502003232号